Tower Research Capital LLC (TRC)

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1533421 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$152,504

+$114,157 QoQ

Shares Held

4,500

+275.6% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#163

of 198 holders

Holding Since

Dec 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,467,357 across 465 Biotechnology names. NAMS ranks #58 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	4,547	$4,218,570
2	BBIO	BridgeBio Pharma, Inc.	38,206	$2,845,582
3	ARWR	Arrowhead Pharmaceuticals, Inc.	34,537	$2,815,110
4	VRTX	Vertex Pharmaceuticals Inc / Ma	4,292	$2,131,964
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,927	$2,108,602
6	AXSM	Axsome Therapeutics, Inc.	6,437	$1,575,584
7	INSM	INSMED Inc	10,927	$1,165,036
8	ROIV	Roivant Sciences Ltd.	32,746	$1,158,880

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$152,504	4,500	+275.6%	Shares	Defined	2026-08-11
2026-03-31	$38,347	1,198	+27.0%	Shares	Other	2026-05-15
2025-12-31	$33,080	943	-68.3%	Shares	Defined	2026-02-17
2025-09-30	$84,522	2,972	+442.3%	Shares	Defined	2025-11-14
2025-06-30	$9,924	548	-23.0%	Shares	Defined	2025-08-15
2025-03-31	$14,573	712	-45.1%	Shares	Other	2025-05-15
2024-12-31	$33,332	1,297	-83.3%	Shares	Other	2025-02-13
2024-09-30	$129,181	7,782	+8743.2%	Shares	Defined	2024-11-14
2022-12-31	$959	88	—	Shares	Other	2023-02-10
No filing history on record for this holder in this stock.